Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

HK:2367 Stock Latest News

RatingsAnalyst Reaffirms Buy on Giant Biogene, Citing Differentiated Pipeline, Scalable Innovation and Attractive Valuation with Strong Dividend Support1w ago

RatingsJill Wu Maintains Buy Rating, Slightly Lowers DCF-Based Target to HK$38.42 While Highlighting Diversified Growth and Injectables Upside2M ago
Company AnnouncementsGiant Biogene’s Interim Profit Drops Amid Rising Expenses2M ago2367
Company AnnouncementsGiant Biogene Wins China Approval for First Recombinant Type III Collagen Neck Filler4M ago2367
Company AnnouncementsGiant Biogene Shareholders Back All AGM Resolutions, Approve Final and Special Dividends5M ago2367

Giant Biogene Declares Final 2025 Cash Dividend and Sets HKD Payout Terms

Company AnnouncementsGiant Biogene Declares Final 2025 Cash Dividend and Sets HKD Payout Terms5M ago2367

Company AnnouncementsGiant Biogene Updates Details of 2025 Special Dividend Payout5M ago2367

Company AnnouncementsGiant Biogene Moves to Replace EY with KPMG as External Auditor5M ago2367

Company AnnouncementsGiant Biogene Sets 2026 AGM to Refresh Board Mandates and Appoint New Auditor5M ago2367
Company AnnouncementsGiant Biogene Moves to Replace EY With KPMG as Auditor6M ago2367
Company AnnouncementsGiant Biogene Reshapes Corporate Secretariat With New Joint Company Secretary6M ago2367
RatingsGiant Biogene: Buy Rating on Recovering Growth, High-Value Injectables, and Valuation Support from Buybacks and Channel Expansion7M ago

Giant Biogene Posts Flat Revenue but Lower Profit and Maintains Robust Dividends for 2025

Company AnnouncementsGiant Biogene Posts Flat Revenue but Lower Profit and Maintains Robust Dividends for 20257M ago2367

Company AnnouncementsGiant Biogene Proposes Final Dividend for 2025 Financial Year7M ago2367

Company AnnouncementsGiant Biogene Announces Special 2025 Dividend, Signaling Confidence in Cash Position7M ago2367

Company AnnouncementsGiant Biogene Sets March Board Meeting to Approve 2025 Results7M ago2367
Company AnnouncementsGiant Biogene Wins China Approval for World-First Collagen–Hyaluronate Skin Implant9M ago2367
Company AnnouncementsGiant Biogene Announces Share Repurchase Plan to Enhance Value11M ago2367
Company AnnouncementsGiant Biogene’s Controlling Shareholder Increases Stake to 54.66%1y ago2367

Giant Biogene Gains Approval for Innovative Collagen Product

Company AnnouncementsGiant Biogene Gains Approval for Innovative Collagen Product1y ago2367

Company AnnouncementsGiant Biogene’s Controlling Shareholder Increases Stake1y ago2367

Company AnnouncementsGiant Biogene’s Controlling Shareholder Increases Stake1y ago2367